GeoVax Labs is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Alan Dodd, with a market cap of $3.3M.
Common questions about GeoVax Labs
GeoVax Labs is scheduled to report earnings for Q1 2026 on April 30, 2026 after market close.
GeoVax Labs has approximately 17 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.